1 Min Read
Nov 9 (Reuters) - Caladrius Biosciences Inc
* Caladrius Biosciences reports 2017 third quarter results
* Q3 loss per share $0.38 from continuing operations Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.